SCSK Corp
TSE:9719
SCSK Corp
TSE:9719
Price:
3 256
JPY
-1.63%
Market Cap:
1T
JPY
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
SCSK Corp
3256
-54 (-1.63%)
| 52 Week Range |
2 376
3 310
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
SCSK Corp
Balance Sheet
Balance Sheet Decomposition
SCSK Corp
SCSK Corp
| Current Assets | 274B |
| Cash & Short-Term Investments | 155.3B |
| Receivables | 92.7B |
| Other Current Assets | 26B |
| Non-Current Assets | 210.1B |
| Long-Term Investments | 24.1B |
| PP&E | 122.4B |
| Intangibles | 32.7B |
| Other Non-Current Assets | 30.8B |
| Current Liabilities | 99.4B |
| Accounts Payable | 33.3B |
| Accrued Liabilities | 11.5B |
| Other Current Liabilities | 54.7B |
| Non-Current Liabilities | 72B |
| Long-Term Debt | 60.3B |
| Other Non-Current Liabilities | 11.7B |
Balance Sheet
SCSK Corp
SCSK Corp
Currency: JPY
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
25 908
|
20 840
|
27 363
|
16 456
|
21 170
|
111 695
|
108 768
|
121 251
|
121 425
|
144 360
|
|
| Cash Equivalents |
25 908
|
20 840
|
27 363
|
16 456
|
21 170
|
111 695
|
108 768
|
121 251
|
121 425
|
144 360
|
|
| Short-Term Investments |
0
|
10 910
|
6 056
|
0
|
0
|
412
|
220
|
1 082
|
199
|
5 010
|
|
| Total Receivables |
64 098
|
63 790
|
66 095
|
67 020
|
75 001
|
80 561
|
83 135
|
84 363
|
97 362
|
100 491
|
|
| Accounts Receivables |
63 655
|
63 332
|
65 717
|
66 624
|
74 667
|
80 537
|
83 079
|
84 363
|
97 320
|
100 491
|
|
| Other Receivables |
443
|
458
|
378
|
396
|
334
|
24
|
56
|
0
|
42
|
0
|
|
| Inventory |
5 075
|
6 178
|
7 170
|
6 086
|
8 308
|
10 071
|
7 710
|
9 125
|
9 748
|
7 939
|
|
| Other Current Assets |
108 506
|
136 457
|
165 622
|
94 122
|
96 528
|
11 152
|
12 691
|
14 234
|
15 365
|
15 034
|
|
| Total Current Assets |
223 444
|
238 175
|
272 306
|
183 684
|
201 007
|
213 891
|
212 524
|
230 055
|
244 099
|
272 834
|
|
| PP&E Net |
64 175
|
66 872
|
68 546
|
73 464
|
70 833
|
87 645
|
106 698
|
113 287
|
120 993
|
113 915
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
87 645
|
106 698
|
113 287
|
120 993
|
113 915
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
27 832
|
33 485
|
37 606
|
42 250
|
48 334
|
|
| Intangible Assets |
7 794
|
8 297
|
11 692
|
9 472
|
8 155
|
17 738
|
18 885
|
18 991
|
19 480
|
21 328
|
|
| Goodwill |
169
|
232
|
133
|
84
|
53
|
7 504
|
7 504
|
7 504
|
7 504
|
11 167
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
7 890
|
8 581
|
8 012
|
8 094
|
9 121
|
|
| Long-Term Investments |
9 675
|
8 075
|
9 564
|
10 625
|
11 773
|
12 992
|
17 640
|
18 457
|
21 944
|
22 715
|
|
| Other Long-Term Assets |
29 033
|
31 025
|
27 296
|
26 585
|
23 023
|
14 581
|
8 567
|
11 303
|
13 355
|
20 320
|
|
| Other Assets |
169
|
232
|
133
|
84
|
53
|
7 504
|
7 504
|
7 504
|
7 504
|
11 167
|
|
| Total Assets |
334 290
N/A
|
352 676
+6%
|
389 537
+10%
|
303 914
-22%
|
314 844
+4%
|
362 241
+15%
|
380 399
+5%
|
407 609
+7%
|
435 469
+7%
|
471 400
+8%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
17 769
|
19 679
|
21 362
|
20 013
|
22 087
|
32 306
|
29 465
|
32 628
|
34 826
|
36 232
|
|
| Accrued Liabilities |
6 718
|
6 533
|
6 613
|
5 730
|
5 967
|
12 054
|
10 985
|
10 540
|
10 889
|
19 408
|
|
| Short-Term Debt |
10 000
|
10 000
|
10 000
|
10 000
|
15 000
|
15 400
|
15 100
|
7 000
|
7 000
|
11 500
|
|
| Current Portion of Long-Term Debt |
16 086
|
5 980
|
25 988
|
5 975
|
843
|
16 598
|
18 864
|
19 160
|
25 718
|
9 529
|
|
| Other Current Liabilities |
110 226
|
114 063
|
119 956
|
28 846
|
28 628
|
25 201
|
23 406
|
31 847
|
29 934
|
28 866
|
|
| Total Current Liabilities |
160 799
|
156 255
|
183 919
|
70 564
|
72 525
|
101 559
|
97 820
|
101 175
|
108 367
|
105 535
|
|
| Long-Term Debt |
31 694
|
36 435
|
26 667
|
32 183
|
41 909
|
51 054
|
51 677
|
52 810
|
45 197
|
52 940
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
425
|
|
| Minority Interest |
5 971
|
6 038
|
6 706
|
7 329
|
1 015
|
358
|
464
|
442
|
493
|
655
|
|
| Other Liabilities |
3 261
|
8 440
|
5 277
|
4 567
|
5 942
|
9 223
|
3 564
|
6 261
|
9 502
|
9 590
|
|
| Total Liabilities |
201 725
N/A
|
207 168
+3%
|
222 569
+7%
|
114 643
-48%
|
121 391
+6%
|
162 194
+34%
|
153 525
-5%
|
160 688
+5%
|
163 559
+2%
|
169 145
+3%
|
|
| Equity | |||||||||||
| Common Stock |
21 152
|
21 152
|
21 152
|
21 152
|
21 152
|
21 152
|
21 152
|
21 152
|
21 285
|
21 420
|
|
| Retained Earnings |
111 277
|
131 974
|
151 792
|
168 420
|
175 263
|
177 828
|
203 893
|
223 300
|
246 812
|
275 551
|
|
| Additional Paid In Capital |
3 061
|
3 054
|
3 047
|
1 299
|
0
|
0
|
0
|
0
|
122
|
162
|
|
| Unrealized Security Profit/Loss |
2 520
|
1 556
|
2 308
|
2 274
|
2 076
|
1 343
|
2 112
|
2 163
|
2 399
|
2 570
|
|
| Treasury Stock |
8 471
|
8 444
|
8 425
|
711
|
694
|
281
|
285
|
293
|
286
|
284
|
|
| Other Equity |
3 033
|
3 784
|
2 906
|
3 163
|
4 344
|
5
|
2
|
599
|
1 578
|
2 836
|
|
| Total Equity |
132 565
N/A
|
145 508
+10%
|
166 968
+15%
|
189 271
+13%
|
193 453
+2%
|
200 047
+3%
|
226 874
+13%
|
246 921
+9%
|
271 910
+10%
|
302 255
+11%
|
|
| Total Liabilities & Equity |
334 290
N/A
|
352 676
+6%
|
389 537
+10%
|
303 914
-22%
|
314 844
+4%
|
362 241
+15%
|
380 399
+5%
|
407 609
+7%
|
435 469
+7%
|
471 400
+8%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
104
|
104
|
311
|
311
|
311
|
312
|
312
|
312
|
312
|
312
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
